Mireia Pinedo-Toledano

Madrid, MD 28006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Synthesis and Ring Expansion of Triflylated Cyclobutenyl MIDA Boronates.

Synthesis and Ring Expansion of Triflylated Cyclobutenyl MIDA Boronates.

Journal: Organic letters

Published: June 25, 2026

Potent inhibition and limited reactivation of human cholinesterases by cholesterol- and quinoline-based oximes.

Potent inhibition and limited reactivation of human cholinesterases by cholesterol- and quinoline-based oximes.

Journal: Toxicology

Published: May 07, 2026

Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.

Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.

Journal: International journal of molecular sciences

Published: January 30, 2026

Masupirdine, a Selective Serotonin 5‑HT6 Receptor Antagonist for Alzheimer's Disease.

Masupirdine, a Selective Serotonin 5‑HT6 Receptor Antagonist for Alzheimer's Disease.

Journal: ACS pharmacology & translational science

Published: December 23, 2025

NLRP3 Inflammasome Role and NLRP3 Inhibitors in Sensorineural Hearing Loss.

NLRP3 Inflammasome Role and NLRP3 Inhibitors in Sensorineural Hearing Loss.

Journal: Biomolecules

Published: November 18, 2025

Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma.

Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 04, 2025

Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma.

Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma.

Journal: Pharmaceutics

Published: October 27, 2025

Coinage Metal-Catalyzed Divergent Heterocyclizations of Underexplored N-Propargyl Hydrazides.

Coinage Metal-Catalyzed Divergent Heterocyclizations of Underexplored N-Propargyl Hydrazides.

Journal: Organic letters

Published: August 27, 2025

Copper-Mediated Divergent Reactivity of Allene-Tethered Carbamates under Radical Conditions.

Copper-Mediated Divergent Reactivity of Allene-Tethered Carbamates under Radical Conditions.

Journal: Organic letters

Published: June 12, 2025

Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease.

Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease.

Journal: ACS pharmacology & translational science

Published: December 06, 2024

Generation and validation of a novel multitarget small molecule in glioblastoma.

Generation and validation of a novel multitarget small molecule in glioblastoma.

Journal: Cell death & disease

Published: November 25, 2024

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases.

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases.

Journal: Journal of medicinal chemistry

Published: September 10, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026